New Medicines for Tropical Diseases in Pregnancy: Catch-22

1. World Health Organization

2007

Maternal mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA and the World Bank.

Available: http://www.who.int/reproductive-health/publications/maternal_mortality_2005/mme_2005.pdf. Accessed 8 May 2008

2. FiskNMAtunR

2008

Market failure and the poverty of new drugs in maternal health.

PLoS Med

5

e22

doi:10.1371/journal.pmed.0050022

3. DesaiMter KuileFONostenFMcGreadyRAsamoaK

2007

Epidemiology and burden of malaria in pregnancy.

Lancet Infect Dis

7

93

104

4. MyintHYTipmaneePNostenFDayNPPukrittayakameeS

2004

A systematic overview of published antimalarial drug trials.

Trans R Soc Trop Med Hyg

98

73

81

5. TagborHKChandramohanDGreenwoodB

2007

The safety of amodiaquine use in pregnant women.

Expert Opin Drug Saf

6

631

635

6. WardSASeveneEJHastingsIMNostenFMcGreadyR

2007

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.

Lancet Infect Dis

7

136

144

7. BarnesKWatkinsWMWhiteNJ

2008

Antimalarial dosing regimens and drug resistance.

Trends Parasitol

4

127

134

8. GreenMDvan EijkAMvan Ter KuileFOAyisiJGPariseME

2007

Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.

J Infect Dis

196

1403

1408

9. China Cooperative Research Group on qinghaosu and its derivatives as antimalarials

1982

Studies on the toxicity of qinghaosu and its derivatives.

J Tradit Chin Med

2

31

38

10. LongoMZanoncelliSManeraDBrugheraMColomboP

2006

Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro.

Reprod Toxicol

21

83

93

11. DondorpANostenFStepniewskaKDayNWhiteNJ

2005

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.

Lancet

366

717

725

12. BarnesKILindegardhNOgundahunsiOOlliaroPPloweCV

2007

World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology.

Malar J

6

122